Advertisement

PentaVision

Optometric Management

Article

Jason Menzo, CEO of the Foundation Fighting Blindness, on IRDs

Industry Insights
"When patients understand that science is advancing and that they are not alone, it can fundamentally change their outlook and trajectory,” he says.

Optometric Management April 1, 2026 Vol 61, Issue March-April 2026
5 Key Takeaways

  • 1

    Inherited retinal diseases (IRDs) can be overwhelming for patients, leading to anxiety and grief over potential vision loss.

  • 2

    Early access to genetic testing and support resources is crucial for empowering patients after an IRD diagnosis.

  • 3

    Eyecare providers need established resources to guide patients through the next steps after an IRD diagnosis.

  • 4

    Advocacy for vision research funding is essential for improving access to treatments for patients with IRDs.

  • 5

    The Foundation Fighting Blindness aims to accelerate the translation of research into effective treatments for IRD patients.